Nutrition and Malnutrition in Liver Disease

Therapy of Digestive Disorders

Volumn , Issue , 2006, Pages 67-83

  McCullough, Arthur J ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 40149108123     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-0317-5.50011-X     Document Type: Chapter

References (116)

1. Achord JL Malnutrition and the role of nutritional support in alcoholic liver disease. Am J Gastroenterol 1987, 82:1-7.
2. Plauath M, Merli M, Kondrup J, et al. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997, 16:43-45.
3. McCullough AJ, Teran JC, Bugianesi E. Guidelines for nutritional therapy in liver disease. In: Klein S, ed. The American Society of Parenteral and Enteral Nutritional Support. Practice manual. Silver Spring, MD: 1998: 1-12.
4. McClave SA, Mitoraj TE, Thielmeier KA Differentiating subtypes (hypoalbuminemia vs marasmic) of protein calorie malnutrition: Incidence and clinical significance in a University Hospital setting. J Parenter Enter Nutr 1992, 16:337-342.
5. McCullough AJ, Falck-Ytter Y Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology 1999, 29:1328-1330.
6. Padillo FJ, Andicoberry B, Pera-Madrazo C, et al. Anorexia and malnutrition in patients with obstructive jaundice. Nutrition 2002, 18:987-990.
7. Patton KM, Aranda-Michael J Nutritional aspects in liver disease and transplantation. Nutr in Clin Prac 2002, 17:332-340.
8. Merli M, Nicotini G, Angeloni S, et al. Malnutrition is a risk factor in cirrhotic patients undergoing surgery. Nutrition 2002, 18:978-986.
9. Roonspisuthipong C, Sobhonslidsuk A, Nantruj K, et al. Nutritional assessment in various stages of liver cirrhosis. Nutrition 2001, 17:761-765.
10. McCullough AJ, Bugianesi E Protein-calorie malnutrition and the etiology of cirrhosis. Am J Gastroenterol 1997, 92:734-737.
11. McCullough Malnutrition in liver disease. Liver Transpl 2000, 6:S85-S96.
12. Dicecio SR, Wieners EJ, Wiesner RAH Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. Mayo Clin Proc 1989, 69:95-99.
13. Kopelman PG Obesity as a medical problem. Nature 2000, 404:635-643.
14. Keefe EB, Gettys C, Esquivel CO Liver transplantation in patients with severe obesity. Transplantation 1994, 57:309-311.
15. Sawyer RG, Pelletier SJ, Pruett TL Increased early morbidity and morality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999, 13:126-130.
16. Dolz C, Ranrich JM, Ibanez J Ascites increases energy expenditure in liver cirrhosis. Gastroenterology 1991, 100:738-744.
17. Allard JP, Chau J, Sandokji K, et al. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites. Am J Gastroenterol 2001, 96:2442-2447.
18. Shaw BW, Wood RP, Gordon RD, et al. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis 1985, 5:385-393.
19. Selberg O, Bottcher J, Tusch G, et al. Identification of high and low risk patients before liver transplantation - a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1999, 25:652-657.
20. Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 1999, 116:1413-1419.
21. Ratziu V, Bonyhay L, Di Martino V, et al. Survival, liver failure, and hepatoellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 2002, 35:1485-1493.
22. Hui JM, Kench JG, Chitturi S, et al. Long term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 2003, 38:420-427.
23. Caldwell SH, Oelsner DH, Iezzoni JC, et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999, 32:689-692.
24. Caldwell SH, Hespenheide EE Subacute liver failure in obese women. Am J Gastroenterol 2002, 97:2058-2067.
25. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002, 123(1):134-140.
26. Younossi ZM, Reddy V, Price LL, et al. Cryptogenic cirrhosis and posttransplantation: nonalcoholic liver disease. Liver Transpl 2001, 7:797-801.
27. McCullough AJ Obesity and its nurturing effects on hepatitis C. Hepatology 2003, 38:557-559.
28. Naveau S, Giraud V, Borottu F Excess weight as a risk factor for alcoholic liver disease. Hepatology 1997, 25:108-111.
29. Reeves HL, Burt AD, Woods S, et al. Hepatic stellate cell activation occurring in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis. J Hepatol 1996, 25:677-683.
30. Ortiz V, Berenguer M, Rayon JM, et al. Contribution of obesity to hepatitis C fibrosis progression. Am J Gastroenterol 2002, 97:2408-2414.
31. Nair S, Verma S, Thuluvath PJ Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002, 35:105-109.
32. Brannfield MY, Chan S, Pregler J, et al. Liver transplantation in obese patients. J Clin Anesth 1996, 8:585-590.
33. Nair S, Cohen DB, Cohen MP, et al. Post-operative morbidity, mortality, cost and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol 2001, 96:842-845.
34. Imber CJ, St.Peter SD, Lopez I, et al. Current practice regarding the use of fatty livers: A transatlantic survey. Liver Transpl 2002, 8:545-549.
35. Burke A, Lucey MR NAFLD, NASH and orthotopic liver transplantation. Fatty liver disease: NASH and related disorders 2004, 208-217. Blackwell Publishing, London. G.C. Farrell, J. George, P.L.M. Hall (Eds.).
36. Campillo B, Bories PPN, Leluan M, et al. Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients. Metabolism 1995, 44:765-770.
37. Falk-Ytter Y, McCullough AJ Nutritional effect of alcoholism. Curr Gastroenterol Rep 2000, 2:331-336.
38. McCullough AJ, Mullen KD, Kalhan SC Defective non-oxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion. Hepatology 1998, 28:1357-1364.
39. Bugianesi E, Kalhan SC, Burkett E, et al. Quantification of gluconeogenesis in cirrhosis: response to glucagons. Gastroenterology 1998, 115:1450-1530.
40. Tessari P Protein metabolism in liver cirrhosis. From albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 2003, 6:79-85.
41. Dasarathy S, Dodig M, Muc SM, et al. Skeletal muscle atrophy is associated with an increased expression of myostatin and impaired satellite cell function in the portacaval anastomosis rat. Am J Physiol Gastrointest Liver Physiol 2004, 287:G1124-G1130.
42. Scharf JG, Schmitz F, Frystyk J, et al. Insulin-like growth factor-1 serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease. J Hepatol 1996, 25:689-699.
43. Picard A, Costa de Oliveira A, Muguerza B, et al. Low doses of insulin-like growth factor-1 improves nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 1997, 26:191-202.
44. McCullough AJ, Raguso C Effect of cirrhosis on energy expenditure. Am J Clin Nutr 1999, 69:1066-1068.
45. Tajika M, Kato M, Muhri H, et al. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002, 18:224-234.
46. Scolario JS, Bowen J, Stoner G, et al. Substrate oxidation in patients with cirrhosis: Comparison with other nutritional markers. J Parenter Enter Nutr 2000, 24:150-153.
47. Teran JC, Mullen KD, McCullough AJ Glutamine: a conditionally essential amino acid in cirrhosis. Am J Clin Nutr 1995, 62:897-900.
48. McCullough AJ, Bugianesi E, Marchesini G, et al. Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998, 115:947-953.
49. Cabre E, Gassull MA Nutritional aspects of liver disease and transplantation. Curr Opin Clin Nutr Metab Care 2001, 4:581-589.
50. Ockenega J, Bischoff SC, Tillman HL Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2000, 119:1656-1667.
51. McCullough AJ, Mullen KD, Kalhan SC Measurement of total body extracellular water in cirrhotic patients with and without ascites. Hepatology 1991, 14:1102-1109.
52. Figueiredo FA, Dickson ER, Pasha TM, et al. Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease. Liver Transpl 2000, 6:575-581.
53. Fiore P, Merli M, Andreoli A A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999, 18:349-351.
54. Jeong SH, Lee JA, Kim JA, et al. Assessment of body composition using dual-energy X-ray absorptiometry in patients with liver cirrhosis; comparison with anthropometry. Korean J Intern Med 1999, 14:64-71.
55. Pirlich M, Selberg O, Boker K The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis. Hepatology 1996, 24:1422-1427.
56. Pirlich M, Schutz T, Spachos T Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000, 32:1208-1215.
57. Kyle UG, Genton L, Mentha G Reliable bioelectrical impedance analysis estimate of fat-free mass in liver, lung and heart transplant patients. J Parenter Enter Nutr 2001, 25:45-51.
58. Schloerb PR, Forster J, Delcore R, et al. Bioelectrical impedance in the clinical evaluation of liver disease. Am J Clin Nutr 1996, 64(Suppl):510-514.
59. Guglielmi FW, Contento F, Laddaga L, et al. Bioelectric impedance analysis experience with male patients with cirrhosis. Hepatology 1991, 13:892-895.
60. Zillikens MC, Van den Berg JWO, Wilson JHP, et al. Whole-body and segmental bioelectrical impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites. Am J Clin Nutr 1992, 55:621-625.
61. Madden AM, Morgan MY A comparison of skinfold anthropometry and bioelectrical impedance analysis for measuring percentage body fat in patients with cirrhosis. J Hepatol 1994, 21:878-883.
62. Hasse J, Strong S, Gorman MA, et al. Subjective global assessment alternative nutrition-assessment technique for liver-transplant candidates. Nutrition 1993, 9(4):339-343.
63. Naveau S, Belda E, Borotto E Comparison of clinical judgment and anthropometric parameters for evaluating nutritional status in patients with alcoholic liver disease. J Hepatol 1995, 23:234-235.
64. Fandersen H, Borre M, Jakobsen J, et al. Decreased muscle strength in patients with alcoholic liver cirrhosis in relation to nutritional status, alcohol abstinence, liver function, and neuropathy. Hepatology 1998, 27:1200-1206.
65. Prijamoko D, Strauss BJG, Lambert JR, et al. Early detection of protein depletion in alcoholic cirrhosis: Role of body composition analysis. Gastroenterology 1993, 105:1839-1845.
66. Crawford DHG, Shepherd RW, Halliday JW, et al. Body composition in nonalcoholic cirrhosis: The effect of disease etiology and severity on nutritional compartments. Gastroenterology 1994, 106:1611-1617.
67. Aranda-Michel J Nutrition in hepatic failure and liver transplantation. Curr Gastroenterol Rep 2001, 3:362-370.
68. Van de Venne WPHGC, Eesterterp KR, van Hook B, et al. Habitual pattern of food intake in patients with liver disease. Clin Nutr 1993, 12:293-297.
69. McCullough AJ, Teran JC, Bugianesi E. Guidelines for nutritional therapy in liver disease. In: Klein ES, ed. The American Society of Parenteral and Enteral Nutritional Support. Practice manual. Silver Spring MD: 1998: 1-12.
70. Plauth M Liver cirrhosis: Rationale and modalities for nutritional support - The European Society of Parenteral and Enteral Nutrition Consensus and beyond. Curr Opin Clin Nutr Metab Care 1999, 2:345-349.
71. Kondrup J, Müller MJ Energy and protein requirements of patients with chronic liver disease. J Hepatol 1997, 27:239-247.
72. Nielsen K, Kondrup J, Martinsen L, et al. Long-term oral refeeding of patients with cirrhosis of the liver. Br J Nutr 1995, 74:557-567.
73. Solomen SM, Kirby DF The refeeding syndrome: A review. J Parenter Enter Nutr 1990, 14:90-97.
74. Müller MJ, Rieger A, Willman O, et al. Metabolic responses to lipid infusion in patients with liver cirrhosis. Clin Nutr 1992, 11:193-206.
75. Crawford D Recent advances in malnutrition and liver disease. What's New in Gastroenterology 1995, 48:1-4.
76. Phillips JR, Angulo P, Peterson T, et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 2001, 96:2745-2750.
77. Munoz SJ, Neubi JE, Balistreri WF Vitamin E deficiency in primary biliary cirrhosis gastrointestinal malabsorption frequency and relation to other lipid soluble vitamins. Hepatology 1989, 9:525-531.
78. Sokol RJ Fat soluble vitamins and their importance in patients with cholestatic liver diseases. Gastroenterol Clin N Amer 1994, 23:673-705.
79. Newsome PN, Beldon I, Moussa Y Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther 2000, 14:1295-1301.
80. Moscarella S, Duchins A, Buzzelli G Lipoperoxidation, trace elements and vitamin E in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 1994, 6:633-636.
81. Mullen K, Denne SC, McCullough AJ, et al. Leucine metabolism in stable cirrhosis. Hepatology 1986, 6:622-630.
82. Chang WK, Chao YC, Tang HS, et al. Effects of carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. J Parenter Enter Nutr 1997, 21:96-97.
83. Swart GR, Zillikans MC, VonVoure JK Effect of late evening snack on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989, 299:1202-1203.
84. Cordoba J, Lopez-Hellin J, Planas M, et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatology 2004, 4:38-43.
85. Mullen KD, Dasarathy S Protein restriction in hepatic encephalopathy: necessary evil or illogical dogma?. J Hepatology 2004, 41:147-148.
86. Kearns PJ, Young H, Garcia G, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992, 102:200-205.
87. Morgan T, Moritz T, Mendenhall C, et al. Protein consumption and hepatic encephalopathy in alcoholic hepatitis. J Am Coll Nutr 1995, 14:152-158.
88. Uribe M, Marquez MA, Guillermo GR Treatment of chronic portosystemic encephalopathy with vegetable and protein diets - a controlled cross over comparison. Dig Dis Sci 1982, 27:1109-1115.
89. Galati JS, Holderman KP, Dalrymple GV, et al. Delayed gastric emptying of both liquids and solid components of a meal in chronic liver disease. Am J Gastroenterol 1994, 89:708-712.
90. Reding P, Duchatean J, Bataille C Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial. Lancet 1984, 2:493-494.
91. Riggio O, Ariosto F, Merli M Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double blind crossover trial. Dig Dis Sci 1991, 36:1204-1208.
92. Chawla R, Wolf DC, Kutner MH, et al. Cysteine may be an essential nutrient in malnourished patients with cirrhosis. Gastroenterology 1989, 97:1514-1520.
93. Halsted CH Nutrition and alcoholic liver disease. Semin Liv Dis 2004, 24:289-304.
94. Cabré E, González-Huix F, Abad A, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics: a randomized controlled trial. Gastroenterology 1990, 99:715-720.
95. De Lédinghen V, Beau P, Mannant PR, et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Dig Dis Sci 1997, 42:536-541.
96. Mendenhall CL, Bongiovanni G, Goldberg SJ, et al. VA cooperative study on alcoholic hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. J Parenter Enter Nutr 1985, 9:590-596.
97. Fulton S, McCullough AJ Treatment of alcoholic hepatitis. Clin Liv Dis 1999, 2:799-819.
98. Cabré E, Rodriguez-Iglesias P, Caballeria J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition. A multicenter randomized trial. Hepatology 2000, 32:36-42.
99. Bouneva I, Kirby DF Management of nonalcoholic fatty liver disease: weight control. Clin Liver Dis 2004, 8:693-713.
100. Agrawal S, Bonkovsky HL Management of nonalcoholic steatohepatitis. J Clin Gastroenterol 2002, 35:253-261.
101. Wang RT, Koretz RL, Yee HF Is weight reduction an effective therapy for nonalcoholic fatty liver disease? A systemic review. Am J Med 2003, 115:554-559.
102. Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2000, 39:1647-1654.
103. Weimann A, Kuse ER, Bechstein WO, et al. Perioperative and enteral nutrition for patients undergoing orthotopic liver transplantation. Results of a questionnaire from 16 European transplant centers. Transpl Int 1998, 11(Suppl):S289-S296.
104. Pomposelli JJ, Burns DL Nutrition support in the liver transplant patient. Nutr Clin Prac 2002, 17:341-349.
105. Patton KM, Aranda-Michel J Nutritional aspects in liver disease and liver transplantation. Nutr Clin Prac 2002, 17:332-340.
106. Campos ACL, Matias JEF, Coelho JCU Nutritional aspects of liver transplantation. Curr Opin Clin Nutr Metab Care 2002, 5:297-307.
107. Figueiredo F, Dickson ER, Pasha T, et al. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000, 70:1347-1352.
108. LeCornu KA, McKiernan FJ, Kapadia SA, et al. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000, 69:1364-1369.
109. Keogh JB, Tsalamandris C, Sewell RB, et al. Bone loss at the proximal femur and reduced lean mass following liver transplantation: a longitudinal study. Nutrition 1999, 15:661-664.
110. Luzi L, Perseghin G, Regalia E, et al. Metabolic effects of liver transplantation in acirrhotic patients. J Clin Invest 1997, 99:692-720.
111. Reich D, Rothstein K, Manzar Beira C, et al. Common medical disorders after liver transplantation. Semin Gastrointest Dis 1998, 9:110-125.
112. Everhart JE, Lambardero M, Lake JR, et al. Weight changes and obesity after liver transplantation: Incidence and risk factors. Liver Transpl Surg 1998, 4:285-298.
113. Correia MITD, Raego LO, Lima AS Post-liver transplant obesity and diabetes. Curr Opin Clin Nutr Metab Care 2003, 6:457-460.
114. Keohane PP, Attrill H, Grimble G Enteral nutrition in malnourished patients with hepatic cirrhosis and acute hepatic encephalopathy. J Parenter Enter Nutr 1983, 7:346-350.
115. Plauth M, Roske AE, Raomaniuk P, et al. Post-feeding hyperammonaemia in patients with transjugular intrahepatic portosystemic shunt and liver cirrhosis: role of small intestinal ammonia and route of nutrient administration. Gut 2000, 46:849-855.
116. Naveau S, Pelletier G, Poynard T A randomized clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986, 6:270-274.